Dr. Julie Makani
Member
Dr. Julie Makani
Julie Makani (born 1970) is a Tanzanian medical researcher. From 2014 she is Wellcome Trust Research Fellow and Associate Professor in the Department of Haematology and Blood Transfusion at the Muhimbili University of Health and Allied Sciences (MUHAS). Also a visiting fellow and consultant to the Nuffield Department of Medicine, University of Oxford, she is based in Dar es Salaam, Tanzania. In 2011, she received the Royal Society Pfizer Award for her work with sickle cell disease.
Dr. Julie Makani is an Associate Professor in the Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences in Tanzania. She completed her undergraduate/postgraduate training at the University of Dar es Salaam, then she continued her training in the UK, receiving the FRCP from the Royal College of Physicians and the PhD from the Open University.
Dr. Julie’s clinical area of interest is haematology, with a focus on sickle cell disease. She has published extensively in this area and established/been a member of a number of networks and projects at national, regional and global level.
One of her projects is the H3ABioNet Genomic Research Network, in which Nicola Mulder, an AIMS South Africa Executive Team Member from UCT, plays a leading role. She has been awarded several honors including the Archbishop Desmond Tutu Leadership Fellowship at the African Leadership Institute.
Representative Publications:
- Sickle cell disease: new opportunities and challenges in Africa
- Sickle cell disease in Africa: an overview of the integrated approach to health, research, education and advocacy in Tanzania, 2004-2016
- Rates and risk factors of hypertension in adolescents and adults with sickle cell anaemia in Tanzania: 10 years’ experience
- Decreased Hepcidin Levels Are Associated with Low Steady-state Hemoglobin in Children With Sickle Cell Disease in Tanzania
- A pilot study of a non-invasive oral nitrate stable isotopic method suggests that arginine and citrulline supplementation increases whole-body NO production in Tanzanian children with sickle cell disease
